|
- 2016
miR-199a-3p靶基因预测及生物信息学分析
|
Abstract:
摘要:目的 为深入研究miR-199a-3p在膀胱癌形成和发展中的作用提供理论依据。方法 分析miR-199a-3p序列,预测其靶基因和转录因子,并对靶基因进行GO富集和KEGG Pathway分析;构建TF-miR-199a-3p-靶基因网络调控图。结果 miR-199a-3p序列在多物种间具有高度保守性;GO分析发现miR-199a-3p的靶基因参与细胞调节、代谢调节、细胞大分子生物合成等生物过程(P<0.01);KEGG Pathway分析发现miR-199a-3p的靶基因显著富集在上皮细胞的细菌入侵通路、ECM受体的相互作用通路、PI3K-Akt信号通路、MAPK信号通路、小细胞肺癌通路、癌症中的蛋白聚糖通路等;根据构建的TF-miR-199a-3p-靶基因网络调控图,挖掘出可能受miR-199a-3p调控的重要基因有MYC、SP1、mTOR、NFκB、NFκB1等。结论 miR-199a-3p可能通过直接靶向作用mTOR,调节PI3K-Akt-mTOR信号通路,从而参与膀胱癌的形成和发展。
ABSTRACT:Objective To provide theoretical guidance for further research on the role of miR-199a-3p in formation and development of bladder cancer. Methods Mature sequence of miR-199a-3p was analyzed; target genes and transcription factors of miRNA-199a-3p were predicted, and the target genes were analyzed for gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway. Then TF-miRNA- mRNA network diagram was constructed. Results Sequences of miR-199a-3p were highly conserved in various species. In GO analysis, the target genes of miR-199a-3p were enriched in many biological processes, such as regulation of cellular process, regulation of macromolecule metabolic process, and regulation of biological process (P<0.01). In KEGG pathway, the target genes were mainly located in bacterial invasion pathway of epithelial cells, ECM-receptor interaction pathway, PI3K-Akt signaling pathway, MAPK signaling pathway, small cell lung cancer pathway, and proteoglycans pathway in the cancer (P<0.05). According to the TF-miRNA-mRNA network diagram, the important genes that might be regulated by miR-199a-3p were MYC, SP1, mTOR, NFκB, and NFκB1. Conclusion miR-199a-3p may directly target mTOR and participate in the formation and development of bladder cancer through regulating PI3K-Akt-mTOR signaling pathway
[1] | CISSELL KA, DEO SK. Trends in microRNA detection[J]. Anal Bioanal Chem, 2009, 394(4):1109-1016. |
[2] | DUAN Z, CHOY E, HARMON D, et al. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration[J]. Mol Cancer Ther, 2011, 10(8):1337-1345. |
[3] | HAN Y, KUANG Y, XUE X, et al. NLK, a novel target of miR-199a-3p, functions as a tumor suppressor in colorectal cancer[J]. Biomed Pharmacother, 2014, 68(5):497-505. |
[4] | SONG G, ZENG H, LI J, et al. miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer[J]. Biol Pharm Bull, 2010, 33(11):1822-1827. |
[5] | WANG Z, MA X, CAI Q, et al. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1[J]. FEBS Lett, 2014, 588(23):4504-4512. |
[6] | RATERT N, MEYER HA, JUNG M, et al. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome[J]. J Mol Diagn, 2013, 15(5):695-705. |
[7] | MINNA E, ROMEO P, DE CECCO L, et al. miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma[J]. Oncotarget, 2014, 5(9):2513-2528. |
[8] | ICHIMI T, ENOKIDA H, OKUNO Y, et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer[J]. Int J Cancer, 2009, 125(2):345-352. |
[9] | 乐?遥?曾宇慧. PI3K /Akt /mTOR信号传导通路与泌尿系统肿瘤[J]. 国际内科学杂志, 2007, 34(9):509-512. |
[10] | CHEN M, CASSIDY A, GU J, et al. Genetic variations in PI3K-Akt-mTOR pathway and bladder cancer risk[J]. Carcinogenesis, 2009, 30(12):2047-2052. |
[11] | SANGUEDOLCE F, CORMIO A, BUFO P, et al. Molecular markers in bladder cancer: Novel research frontiers[J]. Crit Rev Clin Lab Sci, 2015, 8:1-14. |
[12] | QIAN CN, FURGE KA, KNOL J, et al. Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models[J]. Cancer Res, 2009, 69(21):8256-8264. |
[13] | CHEN M, GU J, DELCLOS GL, et al. Genetic variations of the PI3K-Akt-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients[J]. Carcinogenesis, 2010, 31(8):1387-1391. |
[14] | TIAN R, XIE X, HAN J, et al. miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL[J]. Am J Cancer Res, 2014, 4(6):738-750. |
[15] | FORNARI F, MILAZZO M, CHIECO P, et al. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells[J]. Cancer Res, 2010, 70(12):5184-5193. |
[16] | HENRY JC, PARK JK, JIANG J, et al. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines[J]. Biochem Biophys Res Commun, 2010, 403(1):120-125. |
[17] | KINOSE Y, SAWADA K, NAKAMURA K, et al. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma[J]. Oncotarget, 2015, 6(13):11342-11356. |
[18] | SUN CH, CHANG YH, PAN CC. Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder[J]. Histopathology, 2011, 58(7):1054-1063. |